Global Anti-migraine Drugs Market to be Driven by Increasing Awareness Regarding Drugs

A new market research study by Transparency Market Research provides a detailed analysis of the global market for anti-migraine drugs, including the major growth factors, barriers, product segmentation, current trends, major geographical segments, and competitive landscape. The research report, titled “Anti-Migraine Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019,” also presents the historical statistics and forecast figures to the readers, with the help of infographics, graphs, charts, and tables.

The research study has included recommendations given by industry experts, which are expected to help major players and decision-makers design their strategies and policies in an effective manner. Furthermore, the study has segmented the global market for anti-migraine drugs on the basis of type, technology, and geography. The estimated statistics and share of each segment are presented in the scope of the research report.

Anti-migraine drugs refer to therapeutic agents that are to be used against migraine headaches. These drugs help in reducing the intensity of migraine pain. A migraine is more common in women compared to men, due to the fluctuations that are caused due to the changing hormone levels. The increasing number of migraine sufferers across the globe is one of the major factors responsible for the rapid growth of the global market for anti-migraine drugs. Some of the major anti-migraine drugs that are used widely are Zolmitriptan, Sumatriptan, and others.

Migraine headaches cause great distress to the patient and further add to their overall healthcare expenditure. The major types of migraines are common and classic. Patients suffering from a common migraine feel sudden headaches on either one or both sides of the head. On the other hand, patients suffering from classic migraine headaches witness a sudden change in eyesight and many a time experience partial blindness.

View exclusive Global strategic Business report : http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1566

The steady rise in the prevalence of migraine worldwide, growing awareness regarding the availability of effective anti-migraine drugs, increasing level of acceptance, and technological developments are some of the key factors that are projected to augment the growth of the global anti-migraine drugs market throughout the forecast period. On the flip side, the emergence of local players, high genericization, and impending patent expiration are the key factors hampering the growth of the market.

Some of the prominent players operating in the global market for anti-migraine drugs are GlaxoSmithKline plc, Abbott Laboratories, Inc. AstraZeneca plc, Pfizer, Inc., Eisai, Inc., and Eli Lilly and Company. A detailed analysis of the major players, focusing on the product portfolio, business strategies, financial overview, SWOT analysis, and recent developments in the market has been provided in the report.

Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.